The nation of Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years over Washington's demand for confidential information.
This move came to light following a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
A government spokesman later explained that the United States was seeking genetic material for research and commercial purposes but refused to guarantee the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged more dialogue to secure a agreement acceptable to both sides so the country's vital HIV programme can be sustained.
Wider Implications
Zimbabwe's decision follows a similar case in Kenya, where a court blocked a related health funding agreement following concerns were raised about the security of citizens' health data.
After resuming office recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing direct bilateral agreements to enhance transparency and responsibility.
According to reports, 16 African countries have so far agreed to these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration would have delivered immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any corresponding guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," his statement read.
"Put simply, our country would provide the basic resources for medical research with no certainty that the resulting innovations would be accessible to our population should a future disease outbreak arise."
Sovereignty and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were upending frameworks already set up through the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.
"This mechanism is intended to ensure that when a nation contributes its data, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We are open to continued discussions with our American counterparts on how future co-operation might be arranged in a manner that honours the sovereignty and dignity of each country."
Health Experts Response
A leading public health body expressed it recognised the government's concerns, but urged that talks need to persist considering a large portion of the country's HIV programmes relied on foreign aid.
"If technical issues exist, including those relating to data governance or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," the group said.
The halted deal underscores the complex debate between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.